Gts Securities »

Recursion Pharmaceuticals shares owned by Gts Securities

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Gts Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $257k 53k 4.88
2023-09-30 $80k 11k 7.65

More positions owned by Gts Securities

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Meta Platforms Cl A (META)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)
Select Sector Spdr Tr Financial (XLF)

View all positions for Gts Securities

Top funds holding Recursion Pharmaceuticals

Vanguard Group
ARK Investment Management
BlackRock
Baillie Gifford & Co
State Street Corporation
Softbank Group Corp
Kinnevik AB
Mubadala Investment Co PJSC
MIC Capital Management UK
Geode Capital Management
Susquehanna International
Novo A/S
Nvidia Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas

View all funds holding Recursion Pharmaceuticals